(b)(4).Device evaluated by manufacturer: the device was returned for analysis.The shaft was microscopically examined.The device showed a separation of most of the shaft.The only portion that was returned was approximately 33.5cm long from the strain relief.Inspection of the remainder of the device, apart from the observed damage, revealed no other damage or irregularities.No other issues were identified during the product analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause is operational context as device performance was limited due to anatomical/ procedural factors.(b)(4).
|
Reportable based on device analysis completed on 16-feb- 2017.It was reported that leak in the hub occurred.The target location was located in the liver.A direxion hi-flo fathom-16 system was selected for use.During the procedure, it was noted that there was leakage of chemotherapeutic agent from the hub of the device.The procedure was completed with another of the same procedure.No patient complications reported.However, device analysis revealed a separation of most of the shaft.
|